According to the firm's CEO, the delay in launching the io system is due to a decision to automate parts of its platform, resulting in increased multiplexing.
Point-of-care testing, automation, and panelization of nucleic acid amplification testing are the future of the clinical lab ― and will likely change how labs and clinicians relate.
NEW YORK (GenomeWeb) ― In the first update since 2007, the US Preventative Services Task Force recently provided new guidelines to clinicians for chlamydia and gonorrhea screening.
In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.
